Our research is focused on CMC or quality aspects of pharmaceutical drugs and related products with a strong emphasis on the regulatory point of view. A functional quality approach is followed. The full life cycle is being considered: from early discovery, receptor and pre-clinical phases to first in human/animal and post-approval pharmaceutical quality aspects.